Latest market price
17.98
-0.46-2.49%
HQLQT61Tekla Life Sciences Investors·NYSE
17.98-2.49%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 24, 202640-17G40-17G
Aug 28, 2026NPORT-PMonthly portfolio investments report
Aug 21, 2026N-PXAnnual report of proxy voting record
Jul 20, 20264Statement of changes in beneficial ownership
Jun 11, 20263Initial statement of beneficial ownership
Jun 08, 2026N-CSRSCertified shareholder semi-annual report
May 29, 2026NPORT-PMonthly portfolio investments report
Apr 07, 2026DEF 14ADefinitive proxy statement
Mar 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 27, 2026NPORT-PMonthly portfolio investments report
Feb 23, 2026SC 13D/ABeneficial ownership statement (active, amended)
Feb 11, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jan 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Dec 19, 20253Initial statement of beneficial ownership
Dec 18, 20254Statement of changes in beneficial ownership
Dec 08, 2025N-CENAnnual report on Form N-CEN
Dec 08, 2025N-CSRCertified shareholder report
Nov 26, 2025NPORT-PMonthly portfolio investments report
Nov 24, 2025SC 13D/ABeneficial ownership statement (active, amended)
Sep 26, 2025SC 13D/ABeneficial ownership statement (active, amended)
Sep 23, 20254Statement of changes in beneficial ownership
Sep 19, 20254Statement of changes in beneficial ownership
Sep 17, 20254Statement of changes in beneficial ownership
Sep 15, 20254Statement of changes in beneficial ownership